Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
NF-kappa B | 21 | 2023 | 339 | 3.330 |
Why?
|
I-kappa B Kinase | 9 | 2022 | 44 | 2.900 |
Why?
|
NF-kappa B p50 Subunit | 6 | 2024 | 15 | 2.280 |
Why?
|
Protein Multimerization | 6 | 2024 | 103 | 2.050 |
Why?
|
I-kappa B Proteins | 15 | 2024 | 41 | 1.970 |
Why?
|
Models, Molecular | 16 | 2024 | 808 | 1.560 |
Why?
|
Protein Binding | 13 | 2024 | 972 | 1.400 |
Why?
|
Crystallography, X-Ray | 14 | 2024 | 265 | 1.280 |
Why?
|
DNA | 13 | 2024 | 574 | 1.230 |
Why?
|
Interleukin-6 | 2 | 2023 | 153 | 0.930 |
Why?
|
Skeletal Muscle Myosins | 2 | 2024 | 2 | 0.780 |
Why?
|
Protein Structure, Tertiary | 9 | 2019 | 408 | 0.750 |
Why?
|
Lysophospholipids | 2 | 2011 | 19 | 0.740 |
Why?
|
Multiprotein Complexes | 2 | 2020 | 54 | 0.740 |
Why?
|
Myosin Light Chains | 1 | 2019 | 6 | 0.720 |
Why?
|
Myosin Heavy Chains | 1 | 2019 | 19 | 0.710 |
Why?
|
Protein Isoforms | 2 | 2019 | 130 | 0.710 |
Why?
|
Recombinant Proteins | 6 | 2020 | 515 | 0.700 |
Why?
|
Transcription Factor RelA | 9 | 2024 | 40 | 0.680 |
Why?
|
Antibody Specificity | 2 | 2017 | 79 | 0.680 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 290 | 0.650 |
Why?
|
DNA-Binding Proteins | 7 | 2018 | 539 | 0.640 |
Why?
|
Leukotrienes | 1 | 2017 | 4 | 0.600 |
Why?
|
Cysteine | 1 | 2017 | 98 | 0.570 |
Why?
|
Colitis | 1 | 2017 | 65 | 0.560 |
Why?
|
Protein Conformation | 11 | 2017 | 389 | 0.560 |
Why?
|
Drosophila melanogaster | 4 | 2024 | 180 | 0.540 |
Why?
|
Amino Acid Sequence | 7 | 2024 | 1180 | 0.520 |
Why?
|
Dimerization | 13 | 2009 | 112 | 0.480 |
Why?
|
Protein Engineering | 1 | 2014 | 44 | 0.470 |
Why?
|
Immunoglobulin Fab Fragments | 2 | 2011 | 14 | 0.450 |
Why?
|
Myofibrils | 2 | 2024 | 11 | 0.420 |
Why?
|
Armadillo Domain Proteins | 1 | 2011 | 3 | 0.390 |
Why?
|
Animals | 21 | 2024 | 15081 | 0.390 |
Why?
|
Humans | 25 | 2024 | 37093 | 0.380 |
Why?
|
Molecular Chaperones | 1 | 2011 | 61 | 0.380 |
Why?
|
Structure-Activity Relationship | 4 | 2020 | 409 | 0.370 |
Why?
|
Antigen-Antibody Complex | 1 | 2009 | 19 | 0.350 |
Why?
|
Sphingosine | 1 | 2009 | 21 | 0.350 |
Why?
|
Cell Nucleus | 4 | 2024 | 366 | 0.340 |
Why?
|
Drosophila Proteins | 1 | 2011 | 171 | 0.340 |
Why?
|
Mutation | 3 | 2024 | 1095 | 0.340 |
Why?
|
Signal Transduction | 5 | 2023 | 1908 | 0.330 |
Why?
|
Leucine Zippers | 1 | 2008 | 5 | 0.330 |
Why?
|
Phosphorylation | 5 | 2022 | 928 | 0.320 |
Why?
|
Mutant Proteins | 2 | 2020 | 51 | 0.320 |
Why?
|
Bacterial Proteins | 3 | 2019 | 540 | 0.300 |
Why?
|
Solutions | 2 | 2020 | 62 | 0.300 |
Why?
|
Binding Sites | 9 | 2021 | 651 | 0.290 |
Why?
|
Nuclear Proteins | 1 | 2008 | 307 | 0.270 |
Why?
|
ras Proteins | 1 | 2006 | 51 | 0.260 |
Why?
|
Mutagenesis, Site-Directed | 4 | 2016 | 188 | 0.260 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2024 | 8 | 0.240 |
Why?
|
Polyribonucleotides | 1 | 2004 | 2 | 0.240 |
Why?
|
Molecular Mimicry | 1 | 2004 | 16 | 0.240 |
Why?
|
Molecular Sequence Data | 6 | 2011 | 1568 | 0.240 |
Why?
|
Catalytic Domain | 1 | 2024 | 109 | 0.230 |
Why?
|
X-Rays | 1 | 2023 | 18 | 0.230 |
Why?
|
Nuclear Localization Signals | 5 | 2006 | 17 | 0.220 |
Why?
|
Protein Processing, Post-Translational | 1 | 2024 | 173 | 0.220 |
Why?
|
Enzyme Activation | 2 | 2014 | 444 | 0.210 |
Why?
|
Isatin | 1 | 2022 | 1 | 0.210 |
Why?
|
Polyubiquitin | 1 | 2022 | 7 | 0.210 |
Why?
|
Mice | 7 | 2023 | 5913 | 0.210 |
Why?
|
Amino Acids | 1 | 2002 | 145 | 0.200 |
Why?
|
RNA | 1 | 2004 | 241 | 0.200 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 282 | 0.200 |
Why?
|
Myosins | 2 | 2011 | 36 | 0.200 |
Why?
|
Substrate Specificity | 2 | 2014 | 212 | 0.190 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 45 | 0.190 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2020 | 42 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 122 | 0.180 |
Why?
|
Protein Stability | 1 | 2020 | 45 | 0.180 |
Why?
|
Adenosine Triphosphate | 1 | 2021 | 196 | 0.180 |
Why?
|
Protein Structure, Secondary | 4 | 2011 | 183 | 0.170 |
Why?
|
Response Elements | 1 | 2019 | 56 | 0.170 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 312 | 0.170 |
Why?
|
Aging | 1 | 2024 | 664 | 0.170 |
Why?
|
Genome, Human | 1 | 2019 | 135 | 0.160 |
Why?
|
Immune System | 1 | 2019 | 41 | 0.160 |
Why?
|
Base Sequence | 4 | 2008 | 997 | 0.160 |
Why?
|
Coenzymes | 1 | 2018 | 13 | 0.160 |
Why?
|
Molecular Dynamics Simulation | 1 | 2019 | 133 | 0.160 |
Why?
|
Metals | 1 | 2019 | 98 | 0.160 |
Why?
|
Permeability | 1 | 2017 | 67 | 0.150 |
Why?
|
Blood Vessels | 1 | 2017 | 34 | 0.150 |
Why?
|
Protein Subunits | 3 | 2008 | 87 | 0.150 |
Why?
|
Immunization | 1 | 2017 | 92 | 0.150 |
Why?
|
Acute Disease | 1 | 2017 | 147 | 0.140 |
Why?
|
Metyrapone | 1 | 2016 | 5 | 0.140 |
Why?
|
Bacillus megaterium | 1 | 2016 | 3 | 0.140 |
Why?
|
NADPH-Ferrihemoprotein Reductase | 1 | 2016 | 9 | 0.140 |
Why?
|
Palmitic Acid | 1 | 2016 | 24 | 0.140 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2016 | 92 | 0.130 |
Why?
|
Escherichia coli | 3 | 2011 | 453 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 803 | 0.120 |
Why?
|
Marinobacter | 1 | 2013 | 1 | 0.120 |
Why?
|
Borates | 1 | 2013 | 4 | 0.120 |
Why?
|
Iron-Binding Proteins | 1 | 2013 | 3 | 0.120 |
Why?
|
Carrier Proteins | 2 | 2006 | 305 | 0.110 |
Why?
|
Transfection | 2 | 2013 | 523 | 0.110 |
Why?
|
Chromatography, Gel | 1 | 2013 | 50 | 0.110 |
Why?
|
Protein Structure, Quaternary | 1 | 2013 | 64 | 0.110 |
Why?
|
Kinetics | 4 | 2024 | 708 | 0.110 |
Why?
|
Surface Plasmon Resonance | 2 | 2009 | 20 | 0.110 |
Why?
|
Sequence Alignment | 2 | 2011 | 265 | 0.100 |
Why?
|
Flight, Animal | 1 | 2011 | 3 | 0.100 |
Why?
|
Transgenes | 1 | 2011 | 59 | 0.100 |
Why?
|
Disease Models, Animal | 1 | 2017 | 1371 | 0.100 |
Why?
|
Pliability | 1 | 2011 | 5 | 0.100 |
Why?
|
Scattering, Small Angle | 1 | 2011 | 7 | 0.100 |
Why?
|
Circular Dichroism | 3 | 2019 | 62 | 0.090 |
Why?
|
Serine | 2 | 2008 | 75 | 0.090 |
Why?
|
Caenorhabditis elegans | 1 | 2011 | 78 | 0.090 |
Why?
|
Models, Biological | 3 | 2009 | 677 | 0.090 |
Why?
|
Binding Sites, Antibody | 1 | 2009 | 20 | 0.090 |
Why?
|
Peptides | 2 | 2006 | 320 | 0.090 |
Why?
|
Antibody Affinity | 1 | 2009 | 25 | 0.090 |
Why?
|
Molecular Conformation | 1 | 2009 | 152 | 0.080 |
Why?
|
Aplysia | 2 | 2006 | 19 | 0.080 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2009 | 114 | 0.080 |
Why?
|
Casein Kinase II | 1 | 2008 | 15 | 0.080 |
Why?
|
Enzyme Inhibitors | 2 | 2024 | 433 | 0.080 |
Why?
|
Crystallization | 2 | 2016 | 86 | 0.080 |
Why?
|
Gene Expression | 1 | 2011 | 674 | 0.080 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2008 | 53 | 0.080 |
Why?
|
Glycine | 1 | 2008 | 47 | 0.080 |
Why?
|
Receptors, Nicotinic | 2 | 2006 | 106 | 0.080 |
Why?
|
Calcium | 1 | 2009 | 480 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 190 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2019 | 515 | 0.070 |
Why?
|
Receptors, Cholinergic | 1 | 2006 | 28 | 0.070 |
Why?
|
Elapid Venoms | 1 | 2006 | 16 | 0.070 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 2231 | 0.070 |
Why?
|
Acetylcholine | 1 | 2006 | 73 | 0.070 |
Why?
|
Nicotinic Antagonists | 1 | 2005 | 30 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2003 | 269 | 0.070 |
Why?
|
Nicotinic Agonists | 1 | 2005 | 75 | 0.060 |
Why?
|
Ankyrin Repeat | 1 | 2004 | 1 | 0.060 |
Why?
|
Deuterium | 1 | 2004 | 12 | 0.060 |
Why?
|
Synapses | 1 | 2006 | 180 | 0.060 |
Why?
|
Hydrogen | 1 | 2004 | 47 | 0.060 |
Why?
|
Animals, Genetically Modified | 1 | 2024 | 99 | 0.060 |
Why?
|
Cloning, Molecular | 2 | 2001 | 325 | 0.060 |
Why?
|
Transcription Factor RelB | 1 | 2023 | 8 | 0.060 |
Why?
|
Carboplatin | 1 | 2023 | 13 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2006 | 360 | 0.060 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 12 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2023 | 34 | 0.060 |
Why?
|
Binding, Competitive | 2 | 2019 | 111 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2002 | 132 | 0.050 |
Why?
|
Point Mutation | 1 | 2002 | 93 | 0.050 |
Why?
|
Solvents | 1 | 2002 | 99 | 0.050 |
Why?
|
Arginine | 1 | 2002 | 73 | 0.050 |
Why?
|
4-Butyrolactone | 1 | 2022 | 11 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 222 | 0.050 |
Why?
|
Female | 2 | 2023 | 20969 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 128 | 0.050 |
Why?
|
Stem Cells | 1 | 2023 | 141 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 295 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 1039 | 0.050 |
Why?
|
Cytoplasm | 1 | 2001 | 143 | 0.050 |
Why?
|
Zinc Sulfate | 1 | 2019 | 2 | 0.040 |
Why?
|
Molecular Structure | 1 | 2021 | 492 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 1999 | 5 | 0.040 |
Why?
|
Static Electricity | 1 | 1999 | 78 | 0.040 |
Why?
|
Macromolecular Substances | 1 | 1999 | 96 | 0.040 |
Why?
|
Chromatin | 1 | 2019 | 169 | 0.040 |
Why?
|
Ribosomal Proteins | 1 | 2018 | 21 | 0.040 |
Why?
|
Cell Line | 2 | 2018 | 1354 | 0.040 |
Why?
|
Drug Design | 1 | 2019 | 162 | 0.040 |
Why?
|
Hydroxylation | 1 | 2016 | 15 | 0.040 |
Why?
|
Electron Transport | 1 | 2016 | 40 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 213 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2016 | 431 | 0.030 |
Why?
|
Transcription Factors | 1 | 2019 | 681 | 0.030 |
Why?
|
Ligands | 2 | 2006 | 349 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 1103 | 0.030 |
Why?
|
Boron | 1 | 2013 | 6 | 0.030 |
Why?
|
Anions | 1 | 2013 | 39 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 1015 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2011 | 51 | 0.030 |
Why?
|
Chromatography, Affinity | 1 | 2011 | 67 | 0.030 |
Why?
|
Iron | 1 | 2013 | 225 | 0.030 |
Why?
|
Cholinergic Antagonists | 1 | 2006 | 8 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 2006 | 43 | 0.020 |
Why?
|
Ion Channel Gating | 1 | 2006 | 83 | 0.020 |
Why?
|
Thermodynamics | 1 | 2006 | 216 | 0.020 |
Why?
|
Temperature | 1 | 2006 | 286 | 0.020 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2004 | 30 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 91 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 103 | 0.010 |
Why?
|
Amides | 1 | 2004 | 68 | 0.010 |
Why?
|
Threonine | 1 | 2001 | 25 | 0.010 |
Why?
|
Proline | 1 | 2001 | 43 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 562 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 201 | 0.010 |
Why?
|
Plasmids | 1 | 2001 | 246 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 252 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2001 | 128 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2001 | 208 | 0.010 |
Why?
|
Hela Cells | 1 | 2001 | 366 | 0.010 |
Why?
|
Fibroblasts | 1 | 2001 | 272 | 0.010 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 1998 | 1 | 0.010 |
Why?
|
DNA Primers | 1 | 1998 | 286 | 0.010 |
Why?
|
Time Factors | 1 | 2001 | 1742 | 0.010 |
Why?
|